Pierluigi Paracchi is the founder of Genenta Science. Genenta Science has raised $67M in total funding. Latest round: IPO. Backed by CDP Venture Capital.
Pierluigi Paracchi is the Co-founder and CEO of Genenta Science, a clinical-stage immune-gene therapy company. Genenta Science, which spun off from Prof. Luigi Naldini and San Raffaele Milano in Italy, is the only Italian company listed on the Nasdaq under ticker GNTA and is evolving into Saentra Forge ($SAEN). He also serves as Chairman at Fondazione Praexidia.
Full founder directory · Investor directory · Company funding database · Fundraising library